BIOXPRESS THERAPEUTICS

BioXpress Therapeutics SA is a premier partner for high-quality biosimilar monoclonal antibodies for unmet need indications such as cancer, inflammation and autoimmunity, including adaptive immunity. We have made a commitment to be your partner of choice for the full development of your biosimilar biologic. BioXpress Therapeutics is focused on developing the highest quality product under strict European Medicines Agency (EMA) guidelines. We bring together the world's top biologic development, manufacturing and regulatory experts dedicated to your project... BioXpress Therapeutics SA is exclusively focused on the development of biosimilars. With a philosophy that everyone should have access to high quality biologic therapeutics, BioXpress brings speed, efficiency and safety in developing biosimilar mAbs that impact patients' quality of life. The Company was founded by seasoned industry leaders in cell-line development and analytical characterization. From asset identification to..

Also known as: BioXpress, BioXpress Therapeutics SA

Primary location: Geneva Switzerland